Status:
UNKNOWN
To Evaluate the Mechanism of Jing Si Herbal Tea Liquid Packets and Traditional Western Medicine for Psoriasis
Lead Sponsor:
Buddhist Tzu Chi General Hospital
Conditions:
DLQI
PHQ-9
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Psoriasis is a chronic cutaneous inflammatory disease due to immune dysregulation. It caused skin lesions with thickening plaques and heavy silver scales over the patient's body surface area, includin...
Eligibility Criteria
Inclusion
- \- • Subjects were able to give informed consent prior to commencing any trial-related assessments or procedures.
- Subjects were at least 20 years old when they signed the informed consent form.
- At the time of inclusion in this trial, subjects had to have a diagnosis of chronic psoriasis by a dermatologist.
- According to Taiwan's regulations and payment policies, subjects will or have received treatment related to psoriasis. Before being included in the trial, physicians will independently determine the course of treatment with western medicine related to psoriasis.
- The subjects can communicate well with the trial host and understand the contents of the trial case, and follow the trial specifications.
- At the start of the trial, subjects were willing to provide a three-month trial follow-up to record psoriasis severity and dermatological quality of life questionnaires.
Exclusion
- The subject is unwilling or unable to comply with the requirements of the trial.
- Subject participated in an interventional clinical trial at this time or within the past 30 days. However, participation in another PMOS (post-marketing observational trial) or registration trial is acceptable.
- Those who are judged by physicians to be infirm, allergic, cold, chronic disease, poor renal function, children under the age of three, children, pregnant, breastfeeding, menstrual period are not suitable to participate in this research.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05436938
Start Date
July 1 2022
End Date
June 30 2023
Last Update
June 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hualien Tzu Chi Hospital
Hualien City, Hualien, Taiwan, 970